New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2014
08:03 EDTANIPANI Pharmaceuticals enters development agreement with Sterling Pharmaceutical
ANI Pharmaceuticals announced that it has entered into a fee-for-service development agreement for a generic drug product with Sterling Pharmaceutical Services. The product will be developed by Sterling and transferred into ANI's facilities for commercial manufacture and marketing. The current annual market for this product is $60M, according to IMS Health.
News For ANIP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
08:57 EDTANIPANI Pharmaceuticals price target raised to $65 from $55 at Roth Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use